Quorum Sensing Regulates ‘swim-or-stick’ Lifestyle in the Phycosphere

Cong Fei(New York University), Shady A. Amin(University of Washington)
bioRxiv (Cold Spring Harbor Laboratory)
July 26, 2020
10.1101/2020.07.26.221937
Cited by 6

Related Papers

Updated analysis from a phase 2 study of tislelizumab (TIS) monotherapy in patients (pts) with previously treated, locally advanced, unresectable/metastatic microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) solid tumors.
|Journal of Clinical Oncology|2022|5
Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC).
|Journal of Clinical Oncology|2022|4
Updated analysis from a phase 2 study of tislelizumab (TIS) monotherapy in patients (pts) with previously treated, locally advanced, unresectable/metastatic microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) solid tumors.
|Journal of Clinical Oncology|2022|2